Browsing Tag
Johnson & Johnson
103 posts
Janssen Covid-19 vaccine candidate Ad26.COV2.S bags $1bn deal from US govt
Johnson & Johnson (J&J) said that its subsidiary Janssen Pharmaceutical has agreed to manufacture and supply 100 million…
Johnson & Johnson coronavirus vaccine targeted to be launched in early 2021
Johnson & Johnson said that it has selected a lead coronavirus vaccine candidate from constructs it has been…
J&J takeover of Verb Surgical : J&J strikes deal with Verily for full ownership in robotic surgery company
J&J takeover of Verb Surgical : Johnson & Johnson (J&J) has agreed to take full ownership in US…
Janssen to acquire skin disease drug candidate bermekimab from XBiotech
Janssen Biotech acquisition of bermekimab: Janssen Biotech, a Janssen Pharmaceutical Company of Johnson & Johnson, has agreed to…
Janssen bags Stelara FDA approval for ulcerative colitis treatment
Stelara FDA approval for ulcerative colitis treatment : The Janssen Pharmaceutical Companies of Johnson & Johnson has bagged…
Janssen bags Xarelto FDA approval to prevent blood clots in acutely ill patients
Xarelto FDA approval : The Janssen Pharmaceutical Companies of Johnson & Johnson has secured approval from the US…
Janssen’s Ponesimod OPTIMUM trial in MS meets primary endpoint
Ponesimod OPTIMUM trial results : Johnson & Johnson’s Janssen Pharmaceutical said that the phase 3 OPTIMUM clinical trial…
Guselkumab meets primary endpoints in phase 3 psoriatic arthritis program
Johnson & Johnson’s Janssen Pharmaceutical said that its IL-23 p19 inhibitor TREMFYA (guselkumab) met the primary endpoints of…
J&J wraps up $2.1bn acquisition of Japanese cosmetics company Ci:z Holdings
US healthcare conglomerate Johnson & Johnson (J&J) completed its previously announced JPY230 billion ($2.1 billion) acquisition of Japanese…
Amgen submits BLA for Infliximab biosimilar ABP 710 to FDA
Amgen Inc. has officially submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA)…